Purpose. Studies of bacterial transcriptomics during bloodstream infections are limited to-date because unbiased extraction of bacterial mRNA from whole blood in sufficient quantity and quality has proved challenging. Problems include the high excess of human cells, the presence of PCR inhibitors and the short intrinsic half-life of bacterial mRNA. This study aims to provide a framework for the choice of the most suitable sample preparation method.
INTRODUCTION
Bacterial bloodstream infections are a serious and increasing healthcare problem. [1] [2] [3] Therefore, there is growing interest in bacterial RNA extracted from human whole blood for diagnostic and research purposes. [4] [5] [6] Here, we focused on Escherichia coli because it is the most common pathogen found in bloodstream infections [7, 8] and due to its frequent use in sepsis research [9] [10] [11] . The analysis of bacterial gene expression can elucidate the interactions between the pathogen and the host and improves our understanding of infection. Additionally, there is potential for molecular diagnostics as bacterial mRNA can reveal information about the a etiological pathogen as well as its antibiotic susceptibilities. [6] Furthermore, bacterial rRNA can be used for pathogen detection and identification [12] [13] [14] and has an advantage over DNA due to its high copy number [15, 16] .
We suspect that the wider use of bacterial RNA as a tool in the study and diagnostics of bloodstream infections has been hampered by the difficulty of extracting target bacterial RNA from whole blood specimens in sufficient quantity and of adequate purity for further analysis. Co-purification of PCR inhibitors such as haemoglobin [17] , anticoagulants [18] , leucocyte DNA [19] or IgG [20] , the large excess of human blood cells [21] and the presence of nucleases [22] are among the recognized obstacles in the analysis of bacterial DNA from blood, and we expected similar problems with the analysis of bacterial RNA. Another challenge when investigating bacterial gene expression is the intrinsically short half-life of bacterial mRNAs [23, 24] , which requires stabilization immediately after collection of the sample.
Extraction of bacterial rRNA from whole blood has been demonstrated using microfluidic devices [25] and conventional methods [12] . Analysis of bacterial gene expression in whole blood using a variety of other extraction methods has also been reported. In some studies, blood cells were lysed (e.g. with saponin) prior to RNA stabilization [26] , whereas in others, bacterial gene expression was stabilized first, followed by blood cell lysis with erythrocyte lysis buffer [27] [28] [29] . In another approach, the use of dedicated blood cell lysis agents was avoided altogether, and only a reagent for the stabilization of the bacterial gene expression was applied. [6, 30] .
To our knowledge, a systematic analysis of the RNA yield and quality achieved with the different approaches has not been published to date but would benefit future studies. In this work, we present the analysis of different methods of blood cell lysis and RNA stabilization with respect to bacterial RNA yield, integrity and purity. Moreover, we discuss the influence of lysis agents on bacterial gene expression and the effect of co-purified human RNA on the quantification of bacterial mRNA. We used four different lysis buffers.
(1) Ammonium chloride solution (often referred to as red blood cell lysis buffer) is commonly used to remove most of the cellular particles of a whole blood sample and thus facilitates the extraction of bacterial nucleic acids. [31] However, it does not lyse white blood cells, leading to significant copurification of human DNA and RNA. (2) The commercial, chaotropic MolYsis buffer CM is used in a kit designed for the extraction of bacterial DNA from human whole blood [32, 33] and leads to the lysis of all human blood cells. (3) Saponin is known to cause holes in the membranes of mammalian cells [34] , thus leading to specific lysis of these cells. It has been used for the lysis of blood cells to enable the direct detection of bacteria from blood cultures [35, 36] , or to lyse the blood cells for subsequent gene expression studies [26] . Finally, (4) Triton X-100, which, in combination with a high pH buffer, has been described to be a very effective lysis agent for red and white blood cells while pathogens remain intact. [37, 38] .
For the stabilization of the bacterial RNA and the suppression of the synthesis of new RNA molecules, we used the commercially available RNAprotect Bacteria reagent. The main component of this agent is described as tetradecyltrimethylammonium bromide. [39] We applied it either directly to the blood sample or after lysis of the human blood cells. We also investigated the suitability of the commercial PAXgene reagent for the stabilization of bacterial gene expression in whole blood specimens without prior lysis of the blood cells. The reagent was originally designed for the stabilization of human mRNA in whole blood. [40] .
METHODS
Culturing of E. coli cells E. coli CFT073 [41, 42] was used throughout this study. When required, the strain was recovered from a glycerol stock onto LB agar (Fisher Scientific) plates and incubated overnight at 37 C. Overnight liquid cultures were grown in 3 ml Iso-Sensitest (IST) broth (Oxoid) in a Multitron standard shaking incubator (Infors) (37 C; 200 r.p.m.). The next day, 50 µl of the 10 À4 dilution (»10 4 c.f.u.) was added to 3 ml fresh IST broth in a 15 ml reaction tube. The culture was grown for 5 h to mid-exponential phase (37 C; 200 r.p.m.). Bacterial cells from 500 µl of the culture (»2Â10 7 c.f.u.) were harvested by 3 min centrifugation at 5000 g in a 5415D tabletop centrifuge (Eppendorf). The supernatant was discarded, and the pellet was resuspended in 500 µl human whole blood (anticoagulant: EDTA; Seralab) or fresh IST broth. For experiments with low cell numbers, 25 µl of a 10 À2 dilution (»10 4 c.f.u.) of the midlogarithmic culture was spiked directly into 500 µl whole blood or fresh IST broth.
Stabilization of bacterial RNA Four lysis buffers for human whole blood, used for the removal of human cells in the process of bacterial DNA extraction, were tested for their suitability for bacterial RNA extraction. Volumes, concentrations and pH values were as suggested by the manufacturer or as used in the literature. Incubation times were kept the same for all lysis agents to ensure comparability. To lyse blood cells, the blood was mixed with (1) 500 µl 1 % (v/v) Triton X-100 (SigmaAldrich) in cold 500 mM carbonate buffer (pH 10.0) (Sigma-Aldrich), (2) 500 µl 5 % (w/v) saponin (SigmaAldrich) in cold PBS buffer (Fisher Scientific), (3) 500 µl 0.83 % (w/v) NH 4 Cl in cold 0.01 M Tris/HCl buffer (pH 7.5) (Sigma-Aldrich) or (4) 125 µl cold MolYsis buffer CM (Molzym). The samples were incubated for a maximum of 30 s and centrifuged at 8000 g for 3 min to recover the bacterial cells. The supernatant was discarded, and the bacterial pellet was resuspended in a mixture of 500 µl IST broth and 1000 µl RNAprotect Bacteria reagent (Qiagen) . If no dedicated lysis agent was applied, 1000 µl RNAprotect reagent was added directly to the whole blood or the IST broth. Solutions were mixed by inversion, incubated for 15 min at room temperature and then centrifuged at 6000 g for 6 min. The supernatant was discarded, and the remaining pellet was frozen at À80 C until RNA extraction.
Alternatively, blood with bacteria was first stabilized with RNAprotect before adding a lysis agent. After 15 min incubation at room temperature, the solution was centrifuged for 6 min at 6000 g. The supernatant was discarded, and the pellet was resuspended in a mix of 500 µl IST broth and one of the lysis buffers described above. The sample was then incubated at room temperature for 5 min on a roller mixer. After centrifugation at 6000 g for 6 min, the supernatant was decanted and the pellets were frozen at À80 C until RNA extraction.
For stabilization with the PAXgene reagent, 500 µl whole blood with bacteria was mixed with 1.38 ml PAXgene reagent (PreAnalytiX) and incubated overnight at room temperature. The next day, samples were centrifuged at 5000 g for 10 min. The supernatant was discarded, and pellets were washed with 800 µl nuclease-free water (Life Technologies). Samples were centrifuged again (5000 g for 10 min), and RNA extraction was performed immediately as described below.
RNA extraction
RNA was extracted using a modified protocol for the RNeasy Mini kit (Qiagen) . Pellets were resuspended in 200 µl Tris/EDTA buffer (Life Technologies) containing 15 mg lysozyme ml À1 (Sigma-Aldrich) and 10 µl proteinase K (Qiagen) . Depending on the extent of the lysis of the blood cells, the resuspension could be tedious and require time due to the viscosity of the pellet. However, all pellets were resuspended completely. The solution was incubated on a roller mixer for 10 min at room temperature. To lyse the bacterial cells, 700 µl buffer RLT (kit component) with 10 µl b-mercaptoethanol (Sigma-Aldrich) was added. After vigorous vortexing, the samples were incubated for a further 20 min on the roller mixer. Then, 500 µl absolute ethanol (VWR) was added, and the solution was mixed vigorously using a vortex mixer. The lysate (»1.4 ml) was loaded onto an RNeasy spin column in two 700 µl batches by centrifugation at 8000 g for 1 min. The column was washed twice with 350 µl buffer RW1 (kit component) and twice with 500 µl buffer RPE (kit component) and then transferred into a fresh collection tube and centrifuged at 8000 g for 5 min to remove residual ethanol. Finally, the column was transferred to a new 1.5 ml reaction tube. For elution, 45 µl nuclease-free water was added, and the column was centrifuged at 8000 g for 1 min. The flow-through was added to the column again, and the centrifugation was repeated. The eluate was placed on ice immediately. The amount of extracted nucleic acid was assessed by measurement of the absorption at 260 nm using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). The purity of the sample was assessed by measurement of the absorption at 230 and 280 nm.
DNA removal DNA was removed with the TURBO DNA-free kit (Life Technologies) according to the manufacturer's instructions. The concentration and purity of the remaining RNA were again assessed with the NanoDrop ND-1000 spectrophotometer.
Measurement of the RNA integrity RNA integrity was measured by capillary electrophoresis using a 2100 Bioanalyzer instrument (Agilent Technologies) with the RNA 6000 Nano kit (Agilent Technologies) following the manufacturer's instructions.
Real-time PCR
From 12 µl undiluted RNA in a 20 µl reaction, cDNA was synthesized using the Tetro cDNA synthesis kit (Bioline) according to the manufacturer's instructions. The final cDNA was diluted if higher volumes were required to allow for the analysis of multiple genes. A master mix was prepared from the SensiFAST SYBR Lo-ROX reagent (Bioline), nuclease-free water and the corresponding primers (Metabion) (final concentration, 0.4 µM). The primer sequences are depicted in Table 1 .
Mastermix (16 µl) was mixed with 4 µl cDNA template for a total volume of 20 µl per reaction. PCRs were performed on a Mx3000P instrument (Stratagene-Agilent Technologies) using the following conditions: 2 min initial denaturation at 95 C, followed by 40 cycles of 5 s at 95 C, 10 s at 60 C and 20 s at 72 C. The efficiency and specificity of all primers targeting bacterial sequences were assessed beforehand, and only primer pairs with efficiencies higher than 1.95 were used (Figs S1 and S2, available in the online Supplementary Material). Absence of sample contamination by undigested genomic DNA was verified by RNA controls that did not undergo cDNA synthesis ('no RT controls'). Negative controls (blood or IST broth without spiked-in bacteria) were used similarly to ensure the absence of bacterial contamination or unintended primer binding to cDNA synthesized from human RNA.
Influence of Triton X-100 and saponin on bacterial gene expression E. coli CFT073 cells were grown in IST broth to the midlogarithmic phase. A total of 500 µl of the culture containing
»2Â10
7 c.f.u. was treated with 1 ml RNAprotect for 15 min immediately. Another 500 µl of the same culture was treated with either 500 µl 1 % (v/v) Triton X-100 in 500 mM cold carbonate buffer (pH 10.0) or 500 µl 5 % (w/v) saponin in cold PBS buffer for 30 s. After centrifugation (5000 g for 3 min), a mix of 500 µl IST broth and 1 ml RNAprotect was added. RNA was extracted as described above, and cDNA was synthesized from 600 ng RNA. Real-time PCR analysis was performed for two reference genes (gapA, adk) and four genes (rpoS, rpoH, pspA, cpxP) that are known to respond to various stress conditions, such as a high pH, at a transcriptional level [43] [44] [45] [46] [47] . Gene expression analysis was done using the Livak method [48] and gapA for normalization. Briefly, the difference (DC q ) in the C q values between gapA and the gene of interest was calculated in the control (no lysis agent) and under the condition of interest (treatment with Triton X-100 or saponin). Subsequently, the difference of both DC q values was obtained, referred to as DDC q . Error bars represent the SD of the DC q values for each condition.
Impact of spiked-in human RNA on real-time PCR detection of bacterial RNA All steps were carried out in a UV PCR cabinet to avoid contamination. Bacterial RNA was extracted from IST grown cultures; human RNA was extracted from whole blood (without bacteria) after mixing with RNAprotect. The initial concentrations of human and bacterial RNA were determined with the Nanodrop ND-1000 instrument. Appropriate amounts were obtained by serial dilution in nuclease-free water. The combined species were used for cDNA synthesis and quantitative PCR (qPCR) as described above.
Statistical analysis Statistical differences were identified using one-way ANOVA with post hoc Holm-Sidak tests. Differences were statistically significant at P<0.05 (*), P<0.01 (**), P<0.001 (***). The degree of spread of the data is shown as SD.
RESULTS

RNA yield and integrity
In a first step, we compared the total RNA yields after RNA extraction and DNA digest. DNA accounted for about 30 % of the initially extracted nucleic acid. Blood with and without bacteria was either treated with RNAprotect immediately or lysed prior to the stabilization.
The direct mixing of spiked blood and RNAprotect reagent without prior lysis of the human blood cells yielded about 40-50 % of the total bacterial RNA obtained from laboratory medium despite significant co-purification with human RNA (Fig. 1a) .
This method also led to a clotting of the blood sample. The resuspension of the pellet was tedious, time consuming and required some practice (i.e. potentially leading to userdependent variability). Additionally, remainders of the blood caused strong contamination of the silica columns used for nucleic acid purification. Lysis of the human blood cells prior to the stabilization of the bacterial gene expression resulted in a decrease of co-purified human total RNA (Fig. 1a, grey bars) . The effect was rather small for saponin, NH 4 Cl and MolYsis buffer CM, while treatment with Triton X-100 resulted in a strong reduction of the background below the limit of detection of the NanoDrop spectrophotometer. Upon mixing with the whole blood, Triton X-100 degraded the blood cells within seconds and yielded about 60 % of the bacterial RNA compared to an extraction from IST broth. Similarly, saponin caused fast degradation of the human blood cells with only a small debris pellet remaining. However, a significant co-purification of human total RNA was still observed, and the recovery rate for bacterial total RNA was 40 %. The A260/230 and A260/280 ratios of the extracted RNA samples were around 2 for all tested conditions, indicating the absence of high amounts of proteins or other contaminants (Fig. S3) . When the blood was first incubated with RNAprotect and then treated with one of the lysis agents, no improvement in the RNA yield was observed. On the contrary, the RNA quality was lower and the C q values of bacterial mRNAs were higher (data not shown).
To further investigate the reduction of the human RNA background after human blood cell lysis, we measured the remaining amount of human b-actin mRNA by means of qPCR (Fig. 1b) . Samples directly stabilized with RNAprotect without prior treatment with a lysis agent displayed the highest amount of b-actin mRNA. Treatment with Triton X-100 caused an increase of the C q value by »12 units, corresponding to a 3-4 order of magnitude decrease in the concentration of b-actin mRNA. Interestingly, the amount of detectable mRNA was reduced to a similar degree after lysis of the blood cells with saponin, despite large amounts of copurified total RNA (Fig. 1a) . Compared to RNA stabilization without prior application of a lysis agent, the amount of b-actin mRNA was slightly but not significantly lower when the blood cells were lysed with NH 4 Cl or MolYsis buffer CM (Pvalues of 0.84 and 0.68, respectively).
The quality of the extracted RNA was assessed using capillary electrophoresis. The electropherograms are shown in Fig. 2 , and an overview of the resulting RNA integrity numbers (RINs) is given in Fig. 1(c) .
The electropherograms show two distinct peaks for the bacterial 16S and 23S rRNA in all samples. Significant amounts of human 18S rRNA and 28S rRNA were found in those samples that were stabilized immediately with RNAprotect and those treated with NH 4 Cl and MolYsis buffer CM (Fig.  S4) . No peaks for human RNA were detected when the blood was lysed with saponin, although large amounts of human total RNA were measured by the NanoDrop (Fig. 1a) . The observed RINs indicate high-quality RNA (RIN !8) [49] after blood cell lysis with Triton X-100 or saponin.
Finally, the implications of the sample preparation method used on specific mRNA quantities determined by real-time PCR were investigated by comparing the mRNA derived C q values for three bacterial reference genes (gapA, adk, gyrB) (Fig. 1d) . The best C q values, similar to those of the IST reference, were obtained when the blood was lysed with saponin. RNAprotect added directly to the sample or after lysis of the blood cells with Triton X-100 yielded C q values about »1.5 units higher than the IST standard. However, SD values and the DC q values between the genes remained similar compared to the reference. Only after blood cell lysis with NH 4 Cl or MolYsis buffer CM did we find a higher variability in the C q value for gapA.
When bacterial RNA was stabilized with the PAXgene reagent, total RNA yields were slightly lower than with RNAprotect, and the C q values for the investigated bacterial genes were notably higher (Table S1 ). Therefore, RNAprotect was used for the stabilization of bacterial RNA throughout the rest of this study.
Influence of Triton X-100 and saponin on bacterial gene expression
Since Triton X-100 and saponin were found to be the most powerful lysis agents for human blood cells, we investigated their effects on bacterial gene expression by comparing C q values for selected genes from treated and untreated samples extracted from IST broth.
When treated with Triton X-100, the C q values for all investigated genes were significantly higher than for the untreated control despite equal input of total RNA (Fig. 3a) .
Total RNA yields and RINs were similar for treated and untreated samples, indicating that Triton X-100 did not affect the extraction process (Fig. S5) . The average increase in the C q values was dependent on the gene and varied between 0.56 (cpxP) and 1.33 (pspA). We hypothesized that exposure to Triton X-100 leads to cell death. If the synthesis of new mRNA molecules is interrupted, their concentration decreases with a gene-specific half-life.
To investigate the viability of the E. coli cells, a viable cell count before and after incubation with Triton X-100 was performed. The recovery rate of viable bacteria after exposure to Triton X-100 for 3.5 min (time necessary for blood cell lysis and subsequent centrifugation) was »0.001 %. After incubation with saponin, the recovery rate of viable bacteria was »100 %. In this case, C q values were similar to the untreated control except for rpoS and cpxP (Fig. 3c ).
The treatment with either Triton X-100 or saponin was found to cause small but significant changes in the apparent observed expression of the investigated stress response genes (Fig. 3b, d) . A 0.52-fold upregulation in the cpxP levels was observed for Triton X-100, and a 0.42-fold downregulation, for saponin. Furthermore, a 0.26-fold downregulation of rpoS and a 0.58-fold upregulation of rpoH were observed after treatment with Triton X-100 and saponin, respectively.
Impact of spiked-in and co-purified human RNA on real-time PCR detection In the next step, we investigated whether the direct application of RNAprotect to the blood sample without prior lysis of the blood cells was associated with the co-purification of PCR inhibitors. As leucocyte DNA is a known inhibitor of PCR detection of bacterial DNA, we hypothesized that leucocyte RNA could have a similar effect on bacterial RNA as both are transformed into cDNA before quantification. Total bacterial RNA extracted from IST-grown cultures (0.05 ng) was spiked with serial dilutions of human RNA extracted from human whole blood without bacteria. Assuming the extraction efficiency from Fig. 1 (a) (»6 µg RNA from 2Â10 7 cells), this amount of bacterial RNA corresponds to »2Â10 2 c.f.u. For each mix, cDNA synthesis was performed and the C q values of a bacterial (gapA) and a human (b-actin) reference gene were investigated. The results are shown in Table 2 .
With the addition of human RNA, a decrease in the C q value of gapA was observed, which was significant for human RNA quantities between 4 and 400 ng. The lowest C q values were obtained when the bacterial RNA sample was spiked with 40 ng human RNA (corresponding to a human RNA concentration of 2 ng µl À1 in the final cDNA synthesis reaction). The average decrease of the C q value at this concentration was 2.69, corresponding to an apparent increase in the concentration of »6.5-fold. No further improvement was observed at higher concentrations of human RNA. On the contrary, the C q value for gapA increased when 400 ng human total RNA was added. However, the signal was still significantly better compared to the unspiked control.
To investigate the impact of co-purified human RNA throughout the whole sample preparation and extraction process, a much smaller amount (»10 4 c.f.u.) of E. coli cells than in the previous experiments (»2Â10 7 c.f.u.) was spiked into 0.5 ml whole blood to drastically decrease the ratio between bacterial and human RNA. The RNA was stabilized with either RNAprotect immediately or after lysis of the blood cells with Triton X-100 or saponin. Again, a sample extracted from IST broth served as a reference. As a measure for the amount of bacterial mRNA, the C q values for gapA, adk and gyrB were determined (Fig. 4) .
The best signals were obtained when the bacterial RNA was extracted from whole blood after direct stabilization with RNAprotect or after lysis of the blood cells with saponin, while the extraction after blood cell lysis with Triton X-100 showed a lower efficacy, similar to the IST reference. These results confirmed the findings of the spiking experiment (Table 2 ) and demonstrate the beneficial impact of human RNA on the detection of small amounts of bacterial RNA.
DISCUSSION
RNA yield and integrity
The yields of bacterial total RNA and mRNA, as well as the RNA integrities after RNA extraction from human whole blood, were compared to a reference extraction from laboratory medium. The obtained RNA yields matched the numbers described in the literature. Bremer and Dennis [15] determined a total RNA content of 214 µg/10 9 cells (corresponding to 4.28 µg/2Â10 7 cells) for E. coli growing with a doubling time of 24 min. 15Our reference yields from IST broth were slightly higher (»6 µg/2Â10 7 cells), but cells grew with a lower doubling time (19 min) and RNA yields will differ between strains. In whole blood, satisfactory results with respect to the total and mRNA yields were obtained when RNAprotect was added directly to the blood sample, although large amounts of human RNA were co-purified. The method avoids the treatment with a lysis agent, which might alter the gene expression, e.g. by activation of the bacterial stress response. However, the observed contamination of the silica column with debris might lead to clogging and reduction of the binding capacity when using larger volumes of blood. Huge amounts of co-purified human RNA can also interfere with some downstream applications, such as gene expression measurements with microarrays [50, 51] or RNA sequencing [52] . Triton X-100 was the most effective lysis agent and significantly reduced the amount of co-purified human total RNA and mRNA. After lysis of the human blood cells with saponin, the amount of detectable human mRNA was considerably reduced, although there was still a significant remainder of human total RNA. An explanation for this observation might be the high degree of human RNA degradation indicated by the absence of distinct rRNA peaks in the electropherogram (Fig. S4) , as degraded RNA yields significantly higher C q values [53] . The main reason for the rather low efficacy of NH 4 Cl and the MolYsis lysis buffer might be the low temperature and the short exposure time (maximum of 30 s before centrifugation) used in our set-up to keep the impact on bacterial gene expression to a minimum. For the extraction of bacterial DNA from human whole blood, the manual for the MolYsis Basic5 kit recommends 5 min incubation with the lysis buffer at room temperature. [54] For NH 4 Cl, other groups have used incubation times of between 20 and 40 min [55] and found a low efficacy of red blood cell lysis after short incubation [56] .
RNA quality is crucial for downstream applications because of its impact on the results obtained from gene expression measurements using real-time PCR [53, 57] , microarrays [58] or RNA sequencing [59] . In this study, the RIN was satisfactory after lysis of the blood cells with either Triton X-100 or saponin, followed by stabilization with RNAprotect. The RIN was lower for direct stabilization with RNAprotect or after blood cell lysis with NH 4 Cl and MolYsis buffer CM. However, these were the conditions with the highest amounts of co-purified human RNA, which forms a background (Figs 1a and S4) and might interfere with the RIN calculation.
Influence of Triton X-100 and saponin on bacterial gene expression We found an effect of both Triton X-100 and saponin on bacterial gene expression. Saponin kept the cells alive and activated stress response genes (Fig. 3d) . Triton X-100 triggered cell death within the time frame of sample preparation. After cell death, mRNA molecules begin to degrade with a gene-specific half-life of typically 3-8 min [23] until an RNA-stabilizing agent was added. Lysis with Triton X-100 will introduce a bias as mRNA species degrade with different half-lives. Additionally, a stress response might be induced before cell death. In particular, the observed upregulation of cpxP could be a response to the alkaline pH of the Triton X-100 solution. [44] However, for the genes investigated here, the introduced bias was found to be small for both lysis agents. Consequently, all samples should be treated in the same way, i.e. extracted from whole blood using the same lysis agent and incubation times to minimize the impact of the sample preparation bias.
Impact of spiked-in and co-purified human RNA on real-time PCR detection Initial experiments conducted here used bacterial concentrations of 10 7 c.f.u. ml
À1
, which is a common amount for gene expression studies in laboratory set-ups [6, 26, 27] . However, in clinical bloodstream infections, the bacterial concentrations often range between 10 0 and 10 3 c.f.u. ml À1 [60] [61] [62] , drastically decreasing the ratio between bacterial and human RNA. As such low concentrations are relevant for diagnostic applications, we conducted additional experiments with 10 4 c.f.u. (Fig. 4) and bacterial RNA corresponding to 10 2 c.f.u. (Table 2 ). It is important to note that the concentration of cells used in these experiments was defined by the concentration of mRNA per cell (10
À3
-10 copies/ cell in E. coli) [63] . To enhance the feasibility of . Impact of co-purified human RNA on the detection of small amounts of bacterial RNA. mRNA abundance (C q values) for gapA, adk and gyrB was measured after RNA extraction from 10 4 E. coli cells spiked into 0.5 ml whole blood or IST broth. The RNA was extracted from IST broth after stabilization of gene expression with RNAprotect (standard) or from whole blood after direct stabilization with RNAprotect or prior to lysis of the blood cells with Triton X-100 or saponin. No C q values were obtained for the negative control (human whole blood without spiked-in bacteria). n=3. transcription measurements for clinical application, technical advancements for mRNA detection will be required. We found that moderate amounts of co-purified human RNA had a stabilizing effect on small amounts of bacterial RNA. This seems contradictory to observations made by other groups, where a reduction in the human DNA background increased the sensitivity of bacterial DNA detection by means of qPCR [64, 65] , probably by reduction of mispriming and more efficient amplification [21] . The stabilizing effect of the human RNA observed here might be due to a relative reduction of adsorption of bacterial RNA to lab plastics, as well as to a relative protection of the target molecules from trace amounts of RNAses, which outweigh any potential negative effects. Thus, the co-purified human RNA acts as a carrier RNA. Similar protective effects of large amounts of foreign RNA have been described by other groups. [66, 67] Consequently, the direct addition of RNAprotect without prior lysis of the blood cells gave the best results for low numbers of bacterial cells with respect to signal intensity. Similar observations were made after lysis of the human blood cells with saponin. This protocol yielded highly degraded human RNA and facilitated the extraction process considerably by removal of cellular debris.
Conclusion
We successfully demonstrated the extraction of bacterial RNA from human whole blood and discussed the implications of the lysis of human blood cells. A key conclusion of this study is that the selection of the most appropriate sample preparation method depends on factors such as number of bacteria, the impact of human RNA on downstream measurements or, potentially, sample volume. If gene expression experiments are performed with large numbers of bacteria grown in whole blood, direct RNA stabilization with RNAprotect is a good choice since the volume of blood is probably relatively small and a lysis agent that has a potential effect on the bacterial gene expression is not required. However, it is not entirely clear whether RNAprotect works equally effectively in blood and laboratory medium. Furthermore, large amounts of human RNA are co-purified, which may not be desirable for certain subsequent applications such as RNA sequencing or microarray experiments. If the experiment involves large amounts of human whole blood, lysis of human blood cells with Triton X-100 or saponin may be useful as this facilitates the extraction considerably. Under these conditions, the human RNA background is reduced significantly, thus limiting the bias toward downstream applications. This work will facilitate future fundamental studies to understand bacterial gene expression during bloodstream infections as well as diagnostic developments.
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